Coming to America

Join us in Barcelona, Spain for an exclusive event on commercializing your diagnostic product in the US market from some of the leading experts in the industry:

• ​Market Access / reimbursement strategies, considerations, timelines, etc. (product medical policy / Medicare Local Coverage Determination / payor coverage)
• Coding (AMA CPT, PLA, MAAA, MolDX Z, WHO ICD-10 codes, etc.)
• Reimbursement (Clinical Lab Fee Schedule/CMS)
• FDA regulatory pathways, considerations, processes, and timelines
• Impact of recent legislative initiatives on the molecular diagnostic and medical device markets
• Commercial insurance / payor perspective on evidence development, addressing unmet needs, and processes in support of favorable medical policy coverage
• Business development, legal, and fund-raising considerations
• CLIA lab development in the US market (where to establish based on payor sources (e.g., MolDX / Medicare jurisdictions), tax implications, validation nuances and LDT vs. IVD considerations
• End of meeting panel discussion

​Please enter your contact information and we will keep you posted on the venue. We look forward to seeing you in Spain!